KAM
Krensavage Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Sell |
2,114,444
-2,142
| -0.1% | -$16.2K | 8.46% | 5 |
|
|
2025
Q1 | $11.7M | Sell |
2,116,586
-804
| -0% | -$4.44K | 6.46% | 6 |
|
|
2024
Q4 | $12.2M | Buy |
2,117,390
+619,316
| +41% | +$3.56M | 7.2% | 6 |
|
|
2024
Q3 | $15.5M | Buy |
1,498,074
+246,736
| +20% | +$2.56M | 8.7% | 5 |
|
|
2024
Q2 | $16.2M | Buy |
1,251,338
+126,752
| +11% | +$1.64M | 7.45% | 6 |
|
|
2024
Q1 | $19.6M | Buy |
1,124,586
+381,762
| +51% | +$6.67M | 8.71% | 6 |
|
|
2023
Q4 | $6.99M | Buy |
742,824
+7,721
| +1% | +$72.7K | 2.48% | 10 |
|
|
2023
Q3 | $8.21M | Buy |
735,103
+47,490
| +7% | +$530K | 3.02% | 9 |
|
|
2023
Q2 | $14.7M | Buy |
687,613
+84,312
| +14% | +$1.8M | 4.66% | 9 |
|
|
2023
Q1 | $24.4M | Buy |
603,301
+8,483
| +1% | +$343K | 7.41% | 8 |
|
|
2022
Q4 | $27.7M | Buy |
594,818
+5,458
| +0.9% | +$254K | 8.55% | 6 |
|
|
2022
Q3 | $30.6M | Sell |
589,360
-35,408
| -6% | -$1.84M | 9.73% | 5 |
|
|
2022
Q2 | $29.5M | Buy |
624,768
+75,940
| +14% | +$3.59M | 9.76% | 5 |
|
|
2022
Q1 | $39.1M | Sell |
548,828
-15,274
| -3% | -$1.09M | 13.46% | 2 |
|
|
2021
Q4 | $42.2M | Sell |
564,102
-372,675
| -40% | -$27.9M | 14.63% | 3 |
|
|
2021
Q3 | $53.2M | Sell |
936,777
-2,873
| -0.3% | -$163K | 16.69% | 1 |
|
|
2021
Q2 | $41.4M | Buy |
939,650
+76,802
| +9% | +$3.38M | 14.04% | 3 |
|
|
2021
Q1 | $42.6M | Buy |
862,848
+4,037
| +0.5% | +$199K | 14.73% | 1 |
|
|
2020
Q4 | $36.2M | Buy |
858,811
+33,482
| +4% | +$1.41M | 10.56% | 5 |
|
|
2020
Q3 | $37.8M | Buy |
825,329
+62,226
| +8% | +$2.85M | 12.03% | 5 |
|
|
2020
Q2 | $38.3M | Buy |
763,103
+62,785
| +9% | +$3.15M | 10.42% | 5 |
|
|
2020
Q1 | $36M | Buy |
700,318
+210,933
| +43% | +$10.8M | 11.58% | 4 |
|
|
2019
Q4 | $30.2M | Sell |
489,385
-9,489
| -2% | -$586K | 10.32% | 6 |
|
|
2019
Q3 | $30M | Buy |
498,874
+19,298
| +4% | +$1.16M | 11.51% | 5 |
|
|
2019
Q2 | $40.5M | Buy |
479,576
+3,534
| +0.7% | +$298K | 13.13% | 4 |
|
|
2019
Q1 | $45.5M | Sell |
476,042
-58,783
| -11% | -$5.62M | 12.29% | 3 |
|
|
2018
Q4 | $37.9M | Buy |
534,825
+23,639
| +5% | +$1.67M | 12.79% | 3 |
|
|
2018
Q3 | $43.7M | Sell |
511,186
-7,849
| -2% | -$671K | 11.23% | 4 |
|
|
2018
Q2 | $60.2M | Sell |
519,035
-220,703
| -30% | -$25.6M | 15.36% | 2 |
|
|
2018
Q1 | $59.9M | Sell |
739,738
-127,032
| -15% | -$10.3M | 14.52% | 2 |
|
|
2017
Q4 | $50.9M | Sell |
866,770
-147,077
| -15% | -$8.63M | 15.85% | 1 |
|
|
2017
Q3 | $47.4M | Sell |
1,013,847
-91,145
| -8% | -$4.27M | 14.79% | 1 |
|
|
2017
Q2 | $39.8M | Buy |
1,104,992
+6,468
| +0.6% | +$233K | 12.07% | 2 |
|
|
2017
Q1 | $33.8M | Buy |
1,098,524
+42,805
| +4% | +$1.32M | 10.91% | 3 |
|
|
2016
Q4 | $35.4M | Buy |
1,055,719
+55,978
| +6% | +$1.88M | 12.68% | 2 |
|
|
2016
Q3 | $26.6M | Buy |
999,741
+92,811
| +10% | +$2.47M | 9.61% | 3 |
|
|
2016
Q2 | $20M | Buy |
906,930
+24,401
| +3% | +$538K | 7.21% | 4 |
|
|
2016
Q1 | $25.9M | Buy |
882,529
+4,083
| +0.5% | +$120K | 9.3% | 3 |
|
|
2015
Q4 | $29M | Buy |
878,446
+148,138
| +20% | +$4.89M | 9.25% | 2 |
|
|
2015
Q3 | $26.4M | Buy |
730,308
+23,400
| +3% | +$846K | 9.55% | 1 |
|
|
2015
Q2 | $31.8M | Buy |
706,908
+282,892
| +67% | +$12.7M | 11.99% | 1 |
|
|
2015
Q1 | $13M | Buy |
+424,016
| New | +$13M | 5.91% | 7 |
|